Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Monoamine Oxidase Inhibitors and Tryptophan

Research Papers that Mention the Interaction

…,tryptophan, … monoamine oxidase inhibitor (MAOI).1-4However, some of these studies also involved the use of methionine.3-5Tryptophan has been shown to potentiate the antidepressant effects … studies.9-12 Although some of the above studies were of longitudinal type, they were not conducted on patients with periodic illness.
Archives of general psychiatry  •  1969  |  View Paper
Drs OLAV SPIGSET and TOM MJORNDAL (Division of Clinical Pharmacology, Umea University Hospital, Sweden) and Dr OLOF LOVHEIM (Department …: The serotonin syndrome is a potentially lethal, toxic hyperserotoninergic state, most commonly resulting from an interaction between irreversible, non-selective monoamine oxidase inhibitors and agents increasing … reuptake inhibitors or tryptophan.'
BMJ  •  1993  |  View Paper
Drs OLAV SPIGSET and TOM MJORNDAL (Division of Clinical Pharmacology, Umea University Hospital, Sweden) and Dr OLOF LOVHEIM (Department …: The serotonin syndrome is a potentially lethal, toxic hyperserotoninergic state, most commonly resulting from an interaction between irreversible, non-selective monoamine oxidase inhibitors and agents increasing … reuptake inhibitors or tryptophan.'
BMJ  •  1993  |  View Paper
In four studies, all carried out more than 20 years ago, the combination of tryptophan plus a monoamine oxidase inhibitor was significantly better than tryptophan plus placebo in the treatment of depression.
Side effects of the combination of tryptophan and a monoamine oxidase inhibitors have limited the use of this combination.
Journal of psychiatry & neuroscience : JPN  •  1991  |  View Paper
Three cases are presented on patients on an MAOI who developed a transient syndrome of myoclonus, hyperreflexia, jaw quivering, teeth chattering and diaphoresis after L-Tryptophan was added.
Canadian journal of psychiatry. Revue canadienne de psychiatrie  •  1985  |  View Paper
The combination of monoamine oxidase inhibitors and tryptophan --a recognized antidepressant regimen--has been reported to cause behavioral or neurologic toxicity.
The American journal of psychiatry  •  1985  |  View Paper
The author presents two cases of hypomania following the addition of L-tryptophan to an MAOI.
The combination of L-tryptophan and a monoamine oxidase inhibitor (MAOI) has been reported to be an effective antidepressant regimen.
The American journal of psychiatry  •  1985  |  View Paper
The reports by Coppen et al. (1963) and by Pare (1963), that tryptophan was capable of potentiating the antidepressant action of monoamine oxidase inhibitors , were followed by the claim of Coppen et al. (1967) that tryptophan, given alone was as effective as electroconvulsive therapy in the treatment of depression.
Advances in experimental medicine and biology  •  1981  |  View Paper
The combination of monoamine oxidase inhibitors and tryptophan (Coppen et al., 1963; 1967), and tricyclic antidepressants e.g., chlorimipramine and tryptophan (Walinder et al., 1975), may increase 5-HT concentrations at receptor sites and therefore be more effective as an antidepressant than tryptophan alone.
Scottish medical journal  •  1978  |  View Paper
It is suggested that 5-H.T.P. plus carbidopa, L-tryptophan plus a monoamine-oxidase inhibitor , and clonazepam may all act by elevating brain levels of serotonin (5-H.T.) and that some human myoclonic syndromes may be specifically related to a cerebral deficiency of 5-H.T.
The Lancet  •  1975  |  View Paper
Show More